PCV20: Clinical Trials

4 trials of PCV20, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 4

Follow PCV20: new trials by email Literature Review of PCV20 trials Research Report on PCV20

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Prior Pneumococcal Vaccination
31-valent pneumococcal conjugate vaccine, PCV20 - Pneumococcal Disease
Phase 3CompletedVaxcyte, Inc.7522026-02-092026-11-13
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49
31 valent pneumococcal conjugate vaccine, PCV20, PCV21 - Pneumococcal Disease
Phase 3CompletedVaxcyte, Inc.40492025-12-012026-10-16
Study to Assess the Immune Response, the Safety and the Reactogenicity of Respiratory Syncytial Virus (RSV) Prefusion Protein 3 Older Adult (OA) (RSVPreF3 OA) Investigational Vaccine When co Administered With PCV20 in Older Adults
RSVPreF3 OA investigational vaccine, PCV20 - Respiratory Syncytial Virus Infections
Phase 3CompletedGlaxoSmithKline11132023-05-262025-05-18
Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults (V116-003, STRIDE-3)
V116, PCV20 - Pneumococcal Infection
Phase 3CompletedMerck Sharp & Dohme LLC26632022-07-132024-10-26

Conditions studied

Pneumococcal Infections (3)  ·  Pneumonia (2)  ·  Respiratory Syncytial Virus Infections (1)

Sponsors

Vaxcyte, Inc. (2)  ·  GlaxoSmithKline (1)  ·  Merck Sharp & Dohme LLC (1)

Countries

United States (4)  ·  Belgium (2)  ·  Australia (1)  ·  Chile (1)  ·  Germany (1)  ·  New Zealand (1)  ·  Poland (1)  ·  Puerto Rico (1)  ·  South Korea (1)  ·  Spain (1)  ·  Sweden (1)  ·  Taiwan (1)  ·  Turkey (Türkiye) (1)

Results publications

PMID 38964361, PMID 41994955